The ancient Japanese art of flower arranging was the inspiration for a groundbreaking technique to create tiny “artificial brains” that could be used to develop personalized cancer treatments.
The organoids, clusters of thousands of human brain cells, cannot perform a brain’s basic functions, much less generate thought. But they provide a far more authentic model – the first of its kind – for studying how brain tumours grow, and how they can be stopped.
“This puts the tumour within the context of a brain, instead of a flat plastic dish,” said Christian Naus, a professor in the department of cellular and physiological sciences, who conceived the project with a Japanese company that specializes in bioprinting. He shared details about the technique at November’s annual Society for Neuroscience conference in San Diego. “When cells grow in three dimensions instead of two, adhering only to each other and not to plastic, an entirely different set of genes are activated.”
Naus studies glioblastoma, a particularly aggressive brain cancer that usually takes root deep inside the brain, and easily spreads. The standard care is surgery, followed by radiation and/or chemotherapy, but gliomas almost always return because a few malignant cells manage to leave the tumour and invade surrounding brain tissue. From the time of diagnosis, average survival is one year.
The idea for creating a more authentic model of glioblastoma originated when Naus partnered with a Japanese biotechnology company, Cyfuse, that has developed a particular technique for printing human tissues based on the Japanese art of flower arranging known as ikebana. In ikebana, artists use a heavy plate with brass needles sticking up, upon which the stems of flowers are affixed. Cyfuse’s bioprinting technique uses a much smaller plate covered with microneedles.
Working with Naus and research associate Wun Chey Sin, Kaori Harada of Cyfuse skewered small spheres of human neural stem cells on the microneedles. As the stem cells multiplied and differentiated into brain tissue, they merged and formed larger structures known as organoids, about two millimetres to three millimetres in diameter. Although the organoids lack blood vessels, they are small enough to allow oxygen and nutrients to permeate the tissue.
“The cells make their own environment,” said Naus, Canada Research Chair in Gap Junctions and Neurological Disorders. “We’re not doing anything except printing them, and then they self-assemble.”
The team then implanted cancerous glioma cells inside the organoids. Naus found that the gliomas spread into the surrounding normal cells.
Having shown that the tumour invades the surrounding tissue, Naus envisions that such a technique can be used with a patient’s own cells – both their normal brain cells and their cancerous cells – to grow a personalized organoid with a glioma at its core, and then test a variety of possible drugs or combinations of treatment to see if any of them stop the cancer from growing and invading.
“With this method, we can easily and authentically replicate a model of the patient’s brain, or at least some of the conditions under which a tumour grows in that brain,” said Naus. “Then we could feasibly test hundreds of different chemical combinations on that patient’s cells to identify a drug combination that shows the most promising result, offering a personalized therapy for brain cancer patients.”
Receive an email update when we add a new ORGANOIDS article.
The Latest on: Organoids
via Google News
The Latest on: Organoids
- What Organoid Models Can Teach Us About Metastasison November 24, 2020 at 11:04 am
Go inside the lab of Karuna Ganesh and learn what organoids are, what we can learn from them, and the potential impact they have for cancer patients.
- Mini lung organoids replicate COVID-19 pathology in a dishon November 20, 2020 at 4:36 am
Scientists developed a new culture technique for alveolospheres which they used to study how alveolar cells respond to SARS-CoV-2 infection.
- A human tissue screen identifies a regulator of ER secretion as a brain-size determinanton November 19, 2020 at 1:31 pm
This genetic screen in human brain tissue implicates multiple pathways in microcephaly and provides a tool for systematic testing of genes in organoids. Science, this issue p. 935 Loss-of-function ...
- Mini-Lungs in a Lab Dish Mimic Early COVID-19 Infectionon November 19, 2020 at 1:00 am
Researchers have become skilled at growing an array of miniature human organs in the lab. Such lab-grown “organoids” have been put to work to better understand diabetes, fatty liver disease, color ...
- Organoids mimic the early development of the heart in mouse embryoson November 16, 2020 at 8:55 am
Organoids can be used to study early stages of heart development in mouse embryos, a new study shows. Researchers from the École Polytechnique Fédérale de Lausanne, Switzerland, have reported that ...
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientson November 11, 2020 at 4:00 pm
To help address this situation, Ooft et al. developed a method of testing drugs in patient-derived organoids, biopsy-derived cells from individual patients grown in a dish. In a clinical study, the ...
- Organoids produce embryonic hearton November 11, 2020 at 5:16 am
(Nanowerk News) Bioengineers at EPFL have used organoids – tiny lab-grown organs – to mimic the early development of the heart in the mouse embryo. The work is another step towards future ...
- Heart Organoids Mimic the Early Stages of Embryonic Heart Developmenton November 11, 2020 at 4:09 am
Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver. This may be a strategy to enhance gene repair within the ...
- Preliminary analysis of xenograft versus organoidson November 10, 2020 at 9:48 pm
Their preliminary analysis showed that for human organoids, there has been a modest increase in outputs, as measured by number of publications, funding, and publications associated with clinical ...
via Bing News